home / stock / grx / grx news


GRX News and Press, The Gabelli Healthcare & Wellness Trust of Beneficial Interest From 01/18/23

Stock Information

Company Name: The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Stock Symbol: GRX
Market: NYSE
Website: www.gabelli.com

Menu

GRX GRX Quote GRX Short GRX News GRX Articles GRX Message Board
Get GRX Alerts

News, Short Squeeze, Breakout and More Instantly...

GRX - Gabelli Healthcare & WellnessRx Trust Announces Initial Closing of Private Placement of 5.20% Series G Cumulative Preferred Shares

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) is pleased to announce the initial closing of a private placement of 5.20% Series G Cumulative Preferred Shares (“Series G Preferred”) with an aggregate liquidation valu...

GRX - Weekly Closed-End Fund Roundup: VFL Tender Results (December 18, 2022)

Summary 2 out of 23 CEF sectors were positive on price and 2 out of 23 sectors were positive on NAV last week. VFL offers tender results. Why it pays to monitor your CEF holdings for corporate actions. Author's note: This article was released to CEF/ETF Income Laborato...

GRX - HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering

Summary We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds ("CEFs") and bonds. We dive deeper into three specific attractive big-yield opportunities that also have healthy upside potential. We begin with a special focus on...

GRX - Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on December 16, 2022 to common shareholders of record on December 9, 2022. The Fund intends to pay a quarterly distr...

GRX - Buffett Explains Why Smart People Go Broke: Our CEF Criteria

We previously discussed Buffett's explanation for why smart people go broke. We then made the connection to why we generally don't buy CEFs. However, this does not mean that investors should never buy any CEFs under any circumstances. Back in March, we wrote : ...

GRX - GRX: Not Among The Best Closed-End Healthcare-Based Funds

GRX’s total return has been negative, and yield has been quite average over the short term. GRX failed to record double digit average total return over the medium and long term. GRX has a quite high expense ratio and doesn’t have significant investments in any one st...

GRX - Closed-End Funds: Check Up On Valuations

Discounts have been widening in the CEF space as volatility has been kicking up. The widening discounts have been creating more opportunities, but headwinds exist. We screen for several different metrics that bring up funds worth exploring further. For further details see: ...

GRX - Weekly Closed-End Fund Roundup: GUT Rights Offering Results (April 24, 2022)

1 out of 22 CEF sectors positive on price and 1 out of 22 sectors positive on NAV last week. GUT has completed its rights offering, which was oversubscribed. Sidestepping the offering was once again the optimal strategy. For further details see: Weekly Closed-End Fund Ro...

GRX - Buffett Warns Of How Smart People Go Broke: Why We Don't Buy CEFs

Warren Buffett once listed the only 3 ways that a smart person can go broke. We zero in on one of those reasons to explain why it is so dangerous for investors. We then make the connection to why we don't buy CEFs. For further details see: Buffett Warns Of How Smart Peop...

GRX - BME: High Concentration In Large Cap Led To Huge Downfall

BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...

Previous 10 Next 10